Retatrutide (LY3437943) is a synthetic tri-agonist peptide designed to interact with the GLP-1, GIP, and Glucagon receptors. Research indicates it may simultaneously influence multiple metabolic signaling pathways involved in cellular energy regulation.

In laboratory settings, Retatrutide is investigated for its potential to modulate glucose homeostasis and lipid metabolism through receptor binding efficacy that differs from mono- and dual-agonist compounds. This material is strictly for in-vitro analysis and development purposes.